|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.69 CNY | +1.51% |
|
-2.88% | -17.29% |
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 953.9 million compared to CNY 676.61 million a year ago. Net income was CNY 194.05 million compared to CNY 155.95 million a year ago.
Basic earnings per share from continuing operations was CNY 1.73 compared to CNY 1.39 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.29% | 878M | |
| +1.77% | 42.75B | |
| +47.70% | 41.61B | |
| +12.24% | 41.34B | |
| -8.83% | 26.59B | |
| +7.44% | 25.49B | |
| -23.01% | 18.12B | |
| +30.56% | 12.24B | |
| -1.82% | 11.76B | |
| +8.35% | 11B |
BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD. 
